Literature DB >> 11574214

Surgical intervention for pulmonary tuberculosis: analysis of indications and perioperative data relating to diagnostic and therapeutic resections.

J Furák1, I Troján, T Szöke, L Tiszlavicz, Z Morvay, E Csada.   

Abstract

OBJECTIVE: To analyze the data on patients operated on for pulmonary tuberculosis (TB) with (Group I) or without (Group II) a correct TB diagnosis and preoperative anti-TB treatment.
METHODS: Between 1980 and 1997, 144 resections for TB (Groups I+II) were performed. The 80 patients in Group I underwent therapeutic resections: 32 cases involved recurrent cavities or tuberculomas, three involved post-TB bronchiectasis, 13 involved progression of cavities or tuberculomas, and 32 involved persistent tuberculomas after 6 months of anti-TB therapy. The 64 patients in Group II were operated on for a suspicion of malignancy in 49 cases, for cavitary lesions with haemophthysis in six cases, for multiple lesions in seven cases, and for recurrent hydrothorax in two cases.
RESULTS: Groups I and II included 0 and five pneumonectomies, 32 and 29 lobectomies, 48 and 20 wedge resections, 0 and nine videothoracoscopic biopsies, and 0 and one hilar lymphadenectomy, respectively. In Groups I and II, the mean duration of postoperative hospitalization was 13.2 and 10.4 days, and the frequency of postoperative pneumothorax was 11.25 and 4.6%, respectively. The incidence of bronchopleural fistula was 1.25 and 0%, the mortality was 0 and 3.1%, and the morbidity was 53.7 and 35.9% in Groups I and II, respectively. Two patients with active disease died in Group II. Pathology demonstrated that the frequency of acid-fast bacilli in Groups I and II was 40 and 25%, respectively.
CONCLUSIONS: Patients without a correct preoperative TB diagnosis underwent more extensive parenchyma resection. Postoperative complications increased when acid-fast bacilli were present. The lack of preoperative anti-TB treatment did not involve a higher risk of minor complications, but death occurred only in this group.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574214     DOI: 10.1016/s1010-7940(01)00874-0

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

Review 1.  Resurgence of therapeutically destitute tuberculosis: amalgamation of old and newer techniques.

Authors:  Ravindra Kumar Dewan; Loven Moodley
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

2.  Is duration of preoperative anti-tuberculosis treatment a risk factor for postoperative relapse or non-healing of spinal tuberculosis?

Authors:  Hai-Long Ren; Jian-Ming Jiang; Ji-Xing Wang; Dong-Bin Qu; Jian-Ting Chen
Journal:  Eur Spine J       Date:  2016-03-07       Impact factor: 3.134

3.  Outcome of untreated lung nodules with histological but no microbiological evidence of tuberculosis.

Authors:  Che-Liang Chung; Yen-Fu Chen; Yen-Ting Lin; Jann-Yuan Wang; Shuenn-Wen Kuo; Jin-Shing Chen
Journal:  BMC Infect Dis       Date:  2018-10-23       Impact factor: 3.090

4.  Do specialist pulmonologists appropriately utilise thoracic surgery for drug-resistant pulmonary tuberculosis? A survey.

Authors:  G Alexander; R Perumal
Journal:  Afr J Thorac Crit Care Med       Date:  2018-09-07

5.  Comparison of outcome of surgery for tubercular and nontubercular empyema: An analysis of 285 consecutive cases.

Authors:  Arvind Kumar; C Vijay Lingaraju; Mohan Venkatesh Pulle; Belal Bin Asaf; Harsh Vardhan Puri; Sukhram Bishnoi
Journal:  Lung India       Date:  2021 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.